Glenview Capital Management - Q4 2022 holdings

$4.51 Billion is the total value of Glenview Capital Management's 53 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 38.9% .

 Value Shares↓ Weighting
CI SellCIGNA CORP NEW$609,646,051
+13.3%
1,839,941
-5.2%
13.51%
+0.4%
THC BuyTENET HEALTHCARE CORP$434,041,256
+3.9%
8,896,111
+9.8%
9.62%
-7.9%
SPY NewSPDR S&P 500 ETF TRput$274,928,927718,900
+100.0%
6.09%
DXC BuyDXC TECHNOLOGY CO$257,170,655
+8.9%
9,704,553
+0.6%
5.70%
-3.5%
FISV SellFISERV INC$255,021,643
+3.0%
2,523,218
-4.7%
5.65%
-8.8%
MCK SellMCKESSON CORP$244,069,202
+10.0%
650,643
-0.3%
5.41%
-2.5%
GPN BuyGLOBAL PMTS INC$237,505,108
+1.7%
2,391,312
+10.6%
5.26%
-9.9%
USFD SellUS FOODS HLDG CORP$130,776,350
+6.9%
3,844,102
-16.9%
2.90%
-5.2%
UHS NewUNIVERSAL HLTH SVCS INCcl b$127,610,836905,748
+100.0%
2.83%
CCEP BuyCOCA-COLA EUROPACIFIC PARTNE$114,450,276
+30.4%
2,068,877
+0.5%
2.54%
+15.6%
VVV BuyVALVOLINE INC$114,068,848
+32.6%
3,493,686
+2.9%
2.53%
+17.5%
HCA BuyHCA HEALTHCARE INC$105,578,801
+81.3%
439,985
+38.9%
2.34%
+60.6%
BAX SellBAXTER INTL INC$102,448,324
-15.7%
2,009,973
-10.9%
2.27%
-25.3%
UBER SellUBER TECHNOLOGIES INC$99,043,798
-8.7%
4,005,006
-2.1%
2.19%
-19.1%
FMC SellFMC CORP$90,105,101
+4.3%
721,996
-11.7%
2.00%
-7.6%
FLEX BuyFLEX LTDord$86,939,546
+58.3%
4,051,237
+22.9%
1.93%
+40.3%
APTV SellAPTIV PLC$85,797,968
-51.8%
921,271
-59.5%
1.90%
-57.3%
CLVT BuyCLARIVATE PLC$84,047,026
+97.8%
10,077,581
+122.7%
1.86%
+75.3%
DD SellDUPONT DE NEMOURS INC$78,584,507
-14.9%
1,145,046
-37.5%
1.74%
-24.6%
ATVI BuyACTIVISION BLIZZARD INC$74,274,398
+114.7%
970,273
+108.5%
1.65%
+90.3%
CI  CIGNA CORP NEWcall$66,268,000
+19.4%
200,0000.0%1.47%
+5.8%
ALIT BuyALIGHT INC$65,425,143
+418.7%
7,825,974
+354.8%
1.45%
+360.3%
FB NewMETA PLATFORMS INCcl a$63,315,928526,142
+100.0%
1.40%
ESI SellELEMENT SOLUTIONS INC$56,377,813
-10.2%
3,099,385
-19.6%
1.25%
-20.4%
NSC SellNORFOLK SOUTHN CORP$56,079,771
+6.8%
227,578
-9.1%
1.24%
-5.4%
ZI BuyZOOMINFO TECHNOLOGIES INC$52,587,687
+68.6%
1,746,519
+133.3%
1.16%
+49.4%
MYGN BuyMYRIAD GENETICS INC$44,948,614
+61.2%
3,097,768
+112.0%
1.00%
+42.9%
EXPE BuyEXPEDIA GROUP INC$44,198,230
+97.9%
504,546
+111.6%
0.98%
+75.4%
LII BuyLENNOX INTL INC$42,199,215
+27.0%
176,396
+18.2%
0.94%
+12.5%
CTVA SellCORTEVA INC$39,940,657
-48.3%
679,494
-49.8%
0.88%
-54.2%
BKD BuyBROOKDALE SR LIVING INC$37,795,957
-10.1%
13,844,673
+40.6%
0.84%
-20.4%
BKNG  BOOKING HOLDINGS INC$37,462,040
+22.6%
18,5890.0%0.83%
+8.6%
LVS SellLAS VEGAS SANDS CORP$36,801,238
-14.2%
765,576
-33.0%
0.82%
-24.0%
WLTW SellWILLIS TOWERS WATSON PLC LTD$35,256,696
-50.0%
144,152
-59.0%
0.78%
-55.8%
GOOGL NewALPHABET INCcap stk cl a$31,236,596354,036
+100.0%
0.69%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$30,293,887
-9.7%
343,897
-18.0%
0.67%
-20.0%
URI SellUNITED RENTALS INC$27,673,001
-43.3%
77,860
-56.9%
0.61%
-49.8%
PYPL NewPAYPAL HLDGS INC$17,805,000250,000
+100.0%
0.39%
BuyEVOLV TECHNOLOGIES HLDNGS IN$15,485,897
+56.9%
5,979,111
+28.5%
0.34%
+38.9%
TPX NewTEMPUR SEALY INTL INC$13,447,061391,700
+100.0%
0.30%
BFLY  BUTTERFLY NETWORK INC$13,443,287
-47.7%
5,464,7510.0%0.30%
-53.6%
SPLK NewSPLUNK INC$12,588,080146,220
+100.0%
0.28%
DNB BuyDUN & BRADSTREET HLDGS INC$10,755,833
+247.2%
877,311
+250.9%
0.24%
+209.1%
BHC NewBAUSCH HEALTH COS INC$9,420,0001,500,000
+100.0%
0.21%
NEWR SellNEW RELIC INC$9,070,555
-1.7%
160,683
-0.1%
0.20%
-13.0%
DMRC SellDIGIMARC CORP NEW$8,135,600
+9.2%
440,000
-20.0%
0.18%
-3.2%
QSI SellQUANTUM SI INC$7,777,419
-44.5%
4,249,956
-16.6%
0.17%
-50.9%
SABR SellSABRE CORP$7,024,917
-56.3%
1,136,718
-63.6%
0.16%
-61.2%
BLI BuyBERKELEY LTS INC$6,996,614
+5.2%
2,610,677
+12.3%
0.16%
-6.6%
NewISOPLEXIS CORP$3,053,5001,970,000
+100.0%
0.07%
FTCH NewFARFETCH LTDord sh cl a$2,927,473618,916
+100.0%
0.06%
BuyRAPID MICRO BIOSYSTEMS INC$915,742
-62.2%
810,391
+8.1%
0.02%
-67.2%
ABC SellAMERISOURCEBERGEN CORP$705,096
+7.3%
4,255
-12.4%
0.02%0.0%
ExitHYPERFINE INC$0-605,052
-100.0%
-0.01%
ExitENHABIT INC$0-100,565
-100.0%
-0.04%
OHPAU ExitORION ACQUISITION CORPunit 02/19/2026$0-485,001
-100.0%
-0.12%
BSX ExitBOSTON SCIENTIFIC CORP$0-167,213
-100.0%
-0.16%
NOW ExitSERVICENOW INC$0-27,500
-100.0%
-0.26%
EPAM ExitEPAM SYS INC$0-38,500
-100.0%
-0.35%
EHC ExitENCOMPASS HEALTH CORP$0-349,830
-100.0%
-0.40%
ExitBAUSCH PLUS LOMB CORP$0-1,516,684
-100.0%
-0.58%
MSFT ExitMICROSOFT CORP$0-156,754
-100.0%
-0.91%
LGVU ExitLONGVIEW ACQUISITION CORP IIunit 99/99/9999$0-5,000,000
-100.0%
-1.23%
AMZN ExitAMAZON COM INC$0-1,152,511
-100.0%
-3.26%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings